Ambroxol

• Description :

  Ambroxol is indicated as "secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  378.1

• Molecular Formula :

  C13H18Br2N2O

• Notes :

  Research use only, not for human use.

• Receptor :

  CYP3A

• CAS Number :

  18683-91-5